XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Restricted Stock
Common Stock
Common Stock
Options and Restricted Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-in Capital
Restricted Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2020       95.6                
Balance at beginning of period at Dec. 31, 2020 $ 675.7     $ 1.0   $ 346.9     $ 360.2   $ (6.5) $ (25.9)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2020                       1.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Common stock issued during period (in shares)       89.8 0.2              
Common stock issued during period 2,650.2     $ 0.9   2,649.3            
Fair value of replacement awards converted in Topgolf merger     $ 33.1         $ 33.1        
Acquisition of treasury stock (in shares)                       (0.4)
Acquisition of treasury stock (12.5)                     $ (12.5)
Exercise of stock options 0.2         (0.5)           0.7
Compensatory awards released from restriction 0.0         (16.5)           $ 16.5
Compensatory awards released from restriction (in shares)                       0.9
Share-based compensation 4.6         4.6            
Equity adjustment from foreign currency translation (16.3)                   (16.3)  
Change in fair value of derivative instruments, net of tax 5.3                   5.3  
Net income 272.5               272.5      
Balance at end of period (in shares) at Mar. 31, 2021       185.6                
Balance at end of period at Mar. 31, 2021 3,612.8     $ 1.9   3,016.9     632.7   (17.5) $ (21.2)
Treasury stock, balance at end of period (in shares) at Mar. 31, 2021                       0.9
Balance at beginning of period (in shares) at Dec. 31, 2020       95.6                
Balance at beginning of period at Dec. 31, 2020 675.7     $ 1.0   346.9     360.2   (6.5) $ (25.9)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2020                       1.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 348.2                      
Balance at end of period (in shares) at Sep. 30, 2021       186.0                
Balance at end of period at Sep. 30, 2021 3,722.0     $ 1.9   3,037.6     708.4   (25.4) $ (0.5)
Treasury stock, balance at end of period (in shares) at Sep. 30, 2021                       0.0
Balance at beginning of period (in shares) at Dec. 31, 2020       95.6                
Balance at beginning of period at Dec. 31, 2020 675.7     $ 1.0   346.9     360.2   (6.5) $ (25.9)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2020                       1.4
Balance at end of period (in shares) at Dec. 31, 2021   14.7   186.2                
Balance at end of period at Dec. 31, 2021 $ 3,682.9 $ (44.7)   $ 1.9   3,051.6 $ (57.1)   682.2 $ 12.4 (27.3) $ (25.5)
Treasury stock, balance at end of period (in shares) at Dec. 31, 2021 1.0                     1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                      
Balance at beginning of period (in shares) at Mar. 31, 2021       185.6                
Balance at beginning of period at Mar. 31, 2021 $ 3,612.8     $ 1.9   3,016.9     632.7   (17.5) $ (21.2)
Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2021                       0.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Acquisition of treasury stock 0.0         0.3           $ (0.3)
Exercise of stock options (in shares)       0.3               0.8
Exercise of stock options 18.2         (1.4)           $ 19.6
Compensatory awards released from restriction 0.0         (1.8)           $ 1.8
Compensatory awards released from restriction (in shares)                       0.1
Share-based compensation 11.0         11.0            
Equity adjustment from foreign currency translation 6.0                   6.0  
Change in fair value of derivative instruments, net of tax (0.2)                   (0.2)  
Net income 91.7               91.7      
Balance at end of period (in shares) at Jun. 30, 2021       185.9                
Balance at end of period at Jun. 30, 2021 3,739.5     $ 1.9   3,025.0     724.4   (11.7) $ (0.1)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2021                       0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Acquisition of treasury stock (0.4)         0.1           $ (0.5)
Exercise of stock options (in shares)       0.1                
Exercise of stock options 1.1         1.0           0.1
Share-based compensation 11.5         11.5            
Equity adjustment from foreign currency translation (12.9)                   (12.9)  
Change in fair value of derivative instruments, net of tax (0.8)                   (0.8)  
Net income (16.0)               (16.0)      
Balance at end of period (in shares) at Sep. 30, 2021       186.0                
Balance at end of period at Sep. 30, 2021 3,722.0     $ 1.9   3,037.6     708.4   (25.4) $ (0.5)
Treasury stock, balance at end of period (in shares) at Sep. 30, 2021                       0.0
Balance at beginning of period (in shares) at Dec. 31, 2021   14.7   186.2                
Balance at beginning of period at Dec. 31, 2021 $ 3,682.9 $ (44.7)   $ 1.9   3,051.6 (57.1)   682.2 12.4 (27.3) $ (25.5)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2021 1.0                     1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Acquisition of treasury stock (in shares)                       (1.5)
Acquisition of treasury stock $ (34.2)                     $ (34.2)
Compensatory awards released from restriction 0.0         (24.0)           $ 24.0
Compensatory awards released from restriction (in shares)                       1.0
Share-based compensation 13.8         13.8            
Equity adjustment from foreign currency translation (13.4)                   (13.4)  
Change in fair value of derivative instruments, net of tax 9.4                   9.4  
Net income 86.7               86.7      
Balance at end of period (in shares) at Mar. 31, 2022       186.2                
Balance at end of period at Mar. 31, 2022 3,700.5     $ 1.9   2,984.3     781.3   (31.3) $ (35.7)
Treasury stock, balance at end of period (in shares) at Mar. 31, 2022                       1.5
Balance at beginning of period (in shares) at Dec. 31, 2021   14.7   186.2                
Balance at beginning of period at Dec. 31, 2021 $ 3,682.9 $ (44.7)   $ 1.9   3,051.6 $ (57.1)   682.2 $ 12.4 (27.3) $ (25.5)
Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2021 1.0                     1.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Equity adjustment from foreign currency translation $ (84.6)                      
Net income 230.6                      
Balance at end of period (in shares) at Sep. 30, 2022       186.2                
Balance at end of period at Sep. 30, 2022 $ 3,806.5     $ 1.9   3,004.2     925.2   (92.6) $ (32.2)
Treasury stock, balance at end of period (in shares) at Sep. 30, 2022 1.3                     1.3
Balance at beginning of period (in shares) at Mar. 31, 2022       186.2                
Balance at beginning of period at Mar. 31, 2022 $ 3,700.5     $ 1.9   2,984.3     781.3   (31.3) $ (35.7)
Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2022                       1.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Acquisition of treasury stock (0.3)         0.2           $ (0.5)
Exercise of stock options 0.1         (0.2)           0.3
Compensatory awards released from restriction 0.0         (1.8)           $ 1.8
Compensatory awards released from restriction (in shares)                       0.1
Share-based compensation 13.2         13.2            
Equity adjustment from foreign currency translation (33.2)                   (33.2)  
Change in fair value of derivative instruments, net of tax 4.5                   4.5  
Net income 105.4               105.4      
Balance at end of period (in shares) at Jun. 30, 2022       186.2                
Balance at end of period at Jun. 30, 2022 3,790.2     $ 1.9   2,995.7     886.7   (60.0) $ (34.1)
Treasury stock, balance at end of period (in shares) at Jun. 30, 2022                       1.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Acquisition of treasury stock (1.0)                     $ (1.0)
Exercise of stock options 0.5         (0.3)           0.8
Compensatory awards released from restriction 0.0         (2.2)           $ 2.2
Compensatory awards released from restriction (in shares)                       0.1
Share-based compensation 10.4         10.4            
Equity adjustment from foreign currency translation (38.0)                   (38.0)  
Change in fair value of derivative instruments, net of tax 5.4                   5.4  
Issuance of common stock related to convertible notes 0.5         0.5            
Capped call transaction related to convertible note conversion 0.0         0.1           $ (0.1)
Net income 38.5               38.5      
Balance at end of period (in shares) at Sep. 30, 2022       186.2                
Balance at end of period at Sep. 30, 2022 $ 3,806.5     $ 1.9   $ 3,004.2     $ 925.2   $ (92.6) $ (32.2)
Treasury stock, balance at end of period (in shares) at Sep. 30, 2022 1.3                     1.3